These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20575664)

  • 101. 2009 H1N1 influenza virus and immunosuppressive drug.
    Wiwanitkit V
    Arq Bras Cardiol; 2010 Dec; 95(6):768. PubMed ID: 21271194
    [No Abstract]   [Full Text] [Related]  

  • 102. Influenza A (H1N1) induced-myopathy: an important extrapulmonary complication.
    Oliveira AS
    Arq Neuropsiquiatr; 2012 May; 70(5):316-8. PubMed ID: 22618782
    [No Abstract]   [Full Text] [Related]  

  • 103. [On viral influenza. Pathological, virological, serological and bacteriological findings during an 8-year period].
    MUENCH O
    Z Gesamte Inn Med; 1959 Jul; 14():609-19. PubMed ID: 14424995
    [No Abstract]   [Full Text] [Related]  

  • 104. Exploring the global immune landscape of peripheral blood mononuclear cells in H5N6-infected patient with single-cell transcriptomics.
    Gao J; Wei J; Qin S; Liu S; Mo S; Long Q; Tan S; Lu N; Xie Z; Lin J
    BMC Med Genomics; 2023 Oct; 16(1):249. PubMed ID: 37853397
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Whole-Genome Sequence Approach and Phylogenomic Stratification Improve the Association Analysis of Mutations With Patient Data in Influenza Surveillance.
    Van Poelvoorde L; Vanneste K; De Keersmaecker SCJ; Thomas I; Van Goethem N; Van Gucht S; Saelens X; Roosens NHC
    Front Microbiol; 2022; 13():809887. PubMed ID: 35516436
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion.
    Leelayuwatanakul N; Kongpolprom N; Sriprasart T; Phoophiboon V; Thanthitaweewat V; Thawanaphong S; Sirichana W; Chirakalwasan N; Kawkitinarong K; Sittipunt C; Putcharoen O; Paitoonpong L; Suwanpimolkul G; Jantarabenjakul W; Srisawat N; Pachinburavan M
    Respirol Case Rep; 2021 Apr; 9(4):e0733. PubMed ID: 33732466
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Anti-SARS-CoV-2 hyperimmune plasma workflow.
    Annamaria P; Eugenia Q; Paolo S
    Transfus Apher Sci; 2020 Oct; 59(5):102850. PubMed ID: 32540345
    [TBL] [Abstract][Full Text] [Related]  

  • 109. SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
    Hung IF; Cheng VC; Li X; Tam AR; Hung DL; Chiu KH; Yip CC; Cai JP; Ho DT; Wong SC; Leung SS; Chu MY; Tang MO; Chen JH; Poon RW; Fung AY; Zhang RR; Yan EY; Chen LL; Choi CY; Leung KH; Chung TW; Lam SH; Lam TP; Chan JF; Chan KH; Wu TC; Ho PL; Chan JW; Lau CS; To KK; Yuen KY
    Lancet Infect Dis; 2020 Sep; 20(9):1051-1060. PubMed ID: 32539986
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
    Lindholm PF; Ramsey G; Kwaan HC
    Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Influenza A(H1N1)pdm09 Virus Infection in a Captive Giant Panda, Hong Kong.
    Martelli P; Teng JLL; Lee FK; Yeong KY; Fong JYH; Hui SW; Chan KH; Lau SKP; Woo PCY
    Emerg Infect Dis; 2019 Dec; 25(12):2303-2306. PubMed ID: 31742520
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Whole Genome Sequencing of A(H3N2) Influenza Viruses Reveals Variants Associated with Severity during the 2016⁻2017 Season.
    Simon B; Pichon M; Valette M; Burfin G; Richard M; Lina B; Josset L
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30695992
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.
    Tunheim G; Laake I; Robertson AH; Waalen K; Hungnes O; Naess LM; Cox RJ; Mjaaland S; Trogstad L
    Influenza Other Respir Viruses; 2019 Mar; 13(2):191-200. PubMed ID: 30536590
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Risk Factors and Attack Rates of Seasonal Influenza Infection: Results of the Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) Seroepidemiologic Cohort Study.
    Huang QS; Bandaranayake D; Wood T; Newbern EC; Seeds R; Ralston J; Waite B; Bissielo A; Prasad N; Todd A; Jelley L; Gunn W; McNicholas A; Metz T; Lawrence S; Collis E; Retter A; Wong SS; Webby R; Bocacao J; Haubrock J; Mackereth G; Turner N; McArdle B; Cameron J; Reynolds EG; Baker MG; Grant CC; McArthur C; Roberts S; Trenholme A; Wong C; Taylor S; Thomas P; Duque J; Gross D; Thompson MG; Widdowson MA;
    J Infect Dis; 2019 Jan; 219(3):347-357. PubMed ID: 30016464
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Large-scale sequence analysis reveals novel human-adaptive markers in PB2 segment of seasonal influenza A viruses.
    Wen L; Chu H; Wong BH; Wang D; Li C; Zhao X; Chiu MC; Yuan S; Fan Y; Chen H; Zhou J; Yuen KY
    Emerg Microbes Infect; 2018 Mar; 7(1):47. PubMed ID: 29593225
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Quantifying homologous and heterologous antibody titre rises after influenza virus infection.
    Freeman G; Perera RA; Ngan E; Fang VJ; Cauchemez S; Ip DK; Peiris JS; Cowling BJ
    Epidemiol Infect; 2016 Aug; 144(11):2306-16. PubMed ID: 27018720
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Inferring influenza infection attack rate from seroprevalence data.
    Wu JT; Leung K; Perera RA; Chu DK; Lee CK; Hung IF; Lin CK; Lo SV; Lau YL; Leung GM; Cowling BJ; Peiris JS
    PLoS Pathog; 2014 Apr; 10(4):e1004054. PubMed ID: 24699693
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Human antibody responses to avian influenza A(H7N9) virus, 2013.
    Guo L; Zhang X; Ren L; Yu X; Chen L; Zhou H; Gao X; Teng Z; Li J; Hu J; Wu C; Xiao X; Zhu Y; Wang Q; Pang X; Jin Q; Wu F; Wang J
    Emerg Infect Dis; 2014 Feb; 20(2):192-200. PubMed ID: 24447423
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Serological response of patients with influenza A (H1N1) pdm09-associated pneumonia: an observational study.
    Angkasekwinai N; Kaewnapha B; Waywa D; Werarak P; Tongsai S; Chokephaibulkit K; Thamlikitkul V; Siritantikorn S
    PLoS One; 2013; 8(11):e81436. PubMed ID: 24312299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.